Non-Hodgkin lymphoma and idiopathic inflammatory cardiomyopathy

Eur Heart J. 2016 Jun 14;37(23):1859. doi: 10.1093/eurheartj/ehv678. Epub 2015 Dec 18.

Authors

Tobias Rutz¹, John O Prior², Julien Vionnet³, Etienne Pruvot⁴

Affiliations

¹ Service of Cardiology, Centre Hospitalier Universitaire Vaudois (CHUV), Rue du Bugnon 46, 1012 Lausanne, Switzerland tobias.rutz@chuv.ch.
² Service of Nuclear Medicine and Molecular Imaging, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
³ Service of Immunology and Allergy, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
⁴ Service of Cardiology, Centre Hospitalier Universitaire Vaudois (CHUV), Rue du Bugnon 46, 1012 Lausanne, Switzerland.

PMID: 26685141
DOI: 10.1093/eurheartj/ehv678

No abstract available

Publication types

Case Reports

MeSH terms

Anti-Inflammatory Agents / therapeutic use
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Arrhythmias, Cardiac / etiology
Cardiomyopathy, Dilated / complications
Cardiomyopathy, Dilated / diagnosis*
Cardiomyopathy, Dilated / drug therapy
Coronary Angiography / methods
Humans
Lymphoma, Large B-Cell, Diffuse / complications*
Lymphoma, Large B-Cell, Diffuse / drug therapy
Magnetic Resonance Angiography / methods
Methotrexate / therapeutic use
Middle Aged
Multimodal Imaging / methods
Myocarditis / complications
Myocarditis / diagnosis*
Myocarditis / drug therapy
Positron Emission Tomography Computed Tomography / methods
Recurrence
Ventricular Dysfunction, Left / complications
Ventricular Dysfunction, Left / diagnosis

Substances

Anti-Inflammatory Agents
Methotrexate